Emergent BioSolutions Reports Financial Results for Second Quarter 2022

Go back to Emergent BioSolutions Reports Financial Results for Second Quarter 2022
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 5.31 -2.23 (29.58%)
Previous Close $7.54    52 Week High $44.38 
Open $5.95    52 Week Low $24.47 
Day High $5.97    P/E 265.50 
Day Low $5.06    EPS $0.02 
Volume 4,258,944